Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 326

1.

Transforming growth factor beta 1 levels predict echocardiographic changes at three years after adjuvant radiotherapy for breast cancer.

Aula H, Skyttä T, Tuohinen S, Luukkaala T, Hämäläinen M, Virtanen V, Raatikainen P, Moilanen E, Kellokumpu-Lehtinen PL.

Radiat Oncol. 2019 Aug 30;14(1):155. doi: 10.1186/s13014-019-1366-1.

2.

Glycoprotein YKL-40 Is Elevated and Predicts Disease Severity in Puumala Hantavirus Infection.

Outinen TK, Mantula P, Jaatinen P, Hämäläinen M, Moilanen E, Vaheri A, Huhtala H, Mäkelä S, Mustonen J.

Viruses. 2019 Aug 21;11(9). pii: E767. doi: 10.3390/v11090767.

3.

High baseline Tie1 level predicts poor survival in metastatic breast cancer.

Tiainen L, Korhonen EA, Leppänen VM, Luukkaala T, Hämäläinen M, Tanner M, Lahdenperä O, Vihinen P, Jukkola A, Karihtala P, Aho S, Moilanen E, Alitalo K, Kellokumpu-Lehtinen PL.

BMC Cancer. 2019 Jul 24;19(1):732. doi: 10.1186/s12885-019-5959-8.

4.

OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.

Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA, Kraus VB, Lohmander LS, Abbott JH, Bhandari M, Blanco FJ, Espinosa R, Haugen IK, Lin J, Mandl LA, Moilanen E, Nakamura N, Snyder-Mackler L, Trojian T, Underwood M, McAlindon TE.

Osteoarthritis Cartilage. 2019 Jul 3. pii: S1063-4584(19)31116-1. doi: 10.1016/j.joca.2019.06.011. [Epub ahead of print]

PMID:
31278997
5.

Pyrazine-Fused Triterpenoids Block the TRPA1 Ion Channel in Vitro and Inhibit TRPA1-Mediated Acute Inflammation in Vivo.

Mäki-Opas I, Hämäläinen M, Moilanen LJ, Haavikko R, Ahonen TJ, Alakurtti S, Moreira VM, Muraki K, Yli-Kauhaluoma J, Moilanen E.

ACS Chem Neurosci. 2019 Jun 19;10(6):2848-2857. doi: 10.1021/acschemneuro.9b00083. Epub 2019 Apr 29.

PMID:
31034197
6.

Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer.

Tiainen L, Hämäläinen M, Luukkaala T, Tanner M, Lahdenperä O, Vihinen P, Jukkola A, Karihtala P, Moilanen E, Kellokumpu-Lehtinen PL.

Clin Breast Cancer. 2019 Aug;19(4):e522-e533. doi: 10.1016/j.clbc.2019.03.006. Epub 2019 Apr 4.

7.

YKL-40 and adult-onset asthma: Elevated levels in clusters with poorest outcome.

Ilmarinen P, Tuomisto LE, Niemelä O, Hämäläinen M, Moilanen E, Kankaanranta H.

J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2466-2468.e3. doi: 10.1016/j.jaip.2019.03.043. Epub 2019 Apr 4. No abstract available.

8.

Downregulation of microsomal prostaglandin E synthase-1 (mPGES-1) expression in chondrocytes is regulated by MAP kinase phosphatase-1 (MKP-1).

Tuure L, Hämäläinen M, Nummenmaa E, Moilanen T, Moilanen E.

Int Immunopharmacol. 2019 Jun;71:139-143. doi: 10.1016/j.intimp.2019.03.014. Epub 2019 Mar 18.

PMID:
30897501
9.

Assessment of alcohol consumption in depression follow-up using self-reports and blood measures including inflammatory biomarkers.

Archer M, Kampman O, Bloigu A, Bloigu R, Luoto K, Kultti J, Hämäläinen M, Moilanen E, Leinonen E, Niemelä O.

Alcohol Alcohol. 2019 May 1;54(3):243-250. doi: 10.1093/alcalc/agz002.

PMID:
30809628
10.

Status of inflammation and alcohol use in a 6-month follow-up study of patients with major depressive disorder.

Archer M, Niemelä O, Luoto K, Kultti J, Hämäläinen M, Moilanen E, Koivukangas A, Leinonen E, Kampman O.

Alcohol. 2019 Feb 12;81:21-26. doi: 10.1016/j.alcohol.2019.02.001. [Epub ahead of print]

PMID:
30769022
11.

Transient Receptor Potential Ankyrin 1 Enhances Ovalbumin-Induced Acute Allergic Inflammation in Murine Models.

Moilanen LJ, Hämäläinen M, Ilmarinen P, Kankaanranta H, Nieminen RM, Moilanen E, Lehtimäki L.

Int Arch Allergy Immunol. 2019;178(3):238-247. doi: 10.1159/000494932. Epub 2019 Jan 30.

PMID:
30699406
12.

IL-6 in Osteoarthritis: Effects of Pine Stilbenoids.

Laavola M, Leppänen T, Hämäläinen M, Vuolteenaho K, Moilanen T, Nieminen R, Moilanen E.

Molecules. 2018 Dec 29;24(1). pii: E109. doi: 10.3390/molecules24010109.

13.

Monoamine oxidase A inhibition protects the myocardium after experimental acute volume overload.

Huuskonen C, Hämäläinen M, Paavonen T, Moilanen E, Mennander A.

Anatol J Cardiol. 2019 Jan;21(1):39-45. doi: 10.14744/AnatolJCardiol.2018.37336.

14.

Attenuating Effects of Nortrachelogenin on IL-4 and IL-13 Induced Alternative Macrophage Activation and on Bleomycin-Induced Dermal Fibrosis.

Pemmari A, Leppänen T, Paukkeri EL, Scotece M, Hämäläinen M, Moilanen E.

J Agric Food Chem. 2018 Dec 26;66(51):13405-13413. doi: 10.1021/acs.jafc.8b03023. Epub 2018 Dec 12.

PMID:
30458613
15.

MKP-1 promotes anti-inflammatory M(IL-4/IL-13) macrophage phenotype and mediates the anti-inflammatory effects of glucocorticoids.

Pemmari A, Paukkeri EL, Hämäläinen M, Leppänen T, Korhonen R, Moilanen E.

Basic Clin Pharmacol Toxicol. 2019 Apr;124(4):404-415. doi: 10.1111/bcpt.13163. Epub 2018 Dec 28.

PMID:
30388313
16.

Decreases in TGF-β1 and PDGF levels are associated with echocardiographic changes during adjuvant radiotherapy for breast cancer.

Aula H, Skyttä T, Tuohinen S, Luukkaala T, Hämäläinen M, Virtanen V, Raatikainen P, Moilanen E, Kellokumpu-Lehtinen PL.

Radiat Oncol. 2018 Oct 19;13(1):201. doi: 10.1186/s13014-018-1150-7.

17.

Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder.

Sorri A, Järventausta K, Kampman O, Lehtimäki K, Björkqvist M, Tuohimaa K, Hämäläinen M, Moilanen E, Leinonen E.

Brain Behav. 2018 Nov;8(11):e01101. doi: 10.1002/brb3.1101. Epub 2018 Oct 1.

18.

Activity of rheumatoid arthritis correlates with oral inflammatory burden.

Äyräväinen L, Heikkinen AM, Kuuliala A, Ahola K, Koivuniemi R, Peltola J, Suomalainen A, Moilanen E, Hämäläinen M, Laasonen L, Meurman JH, Leirisalo-Repo M.

Rheumatol Int. 2018 Sep;38(9):1661-1669. doi: 10.1007/s00296-018-4108-z. Epub 2018 Jul 24.

PMID:
30043237
19.

Anti-rheumatic medication and salivary MMP-8, a biomarker for periodontal disease.

Äyräväinen L, Heikkinen AM, Kuuliala A, Ahola K, Koivuniemi R, Moilanen E, Hämäläinen M, Tervahartiala T, Meurman JH, Leirisalo-Repo M, Sorsa T.

Oral Dis. 2018 Nov;24(8):1562-1571. doi: 10.1111/odi.12930. Epub 2018 Jul 18.

PMID:
29969841
20.

S100B, NSE and MMP-9 fail to predict neurologic outcome while elevated S100B associates with milder initial clinical presentation after aneurysmal subarachnoid hemorrhage.

Kiiski H, Långsjö J, Tenhunen J, Ala-Peijari M, Huhtala H, Hämäläinen M, Moilanen E, Peltola J.

J Neurol Sci. 2018 Jul 15;390:129-134. doi: 10.1016/j.jns.2018.04.030. Epub 2018 Apr 20.

PMID:
29801873
21.

Gene expression in adverse reaction to metal debris around metal-on-metal arthroplasty: An RNA-Seq-based study.

Pemmari A, Leppänen T, Paukkeri EL, Eskelinen A, Moilanen T, Moilanen E.

J Trace Elem Med Biol. 2018 Jul;48:149-156. doi: 10.1016/j.jtemb.2018.03.014. Epub 2018 Mar 20.

PMID:
29773173
22.

Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner.

Eräsalo H, Hämäläinen M, Leppänen T, Mäki-Opas I, Laavola M, Haavikko R, Yli-Kauhaluoma J, Moilanen E.

J Nat Prod. 2018 May 25;81(5):1131-1142. doi: 10.1021/acs.jnatprod.7b00384. Epub 2018 May 4.

PMID:
29726680
23.

Inflammatory biomarkers in saliva and serum of patients with rheumatoid arthritis with respect to periodontal status.

Äyräväinen L, Heikkinen AM, Kuuliala A, Ahola K, Koivuniemi R, Laasonen L, Moilanen E, Hämäläinen M, Tervahartiala T, Meurman JH, Leirisalo-Repo M, Sorsa T.

Ann Med. 2018 Jun;50(4):333-344. doi: 10.1080/07853890.2018.1468922. Epub 2018 Apr 30.

PMID:
29683364
24.

Low tumor necrosis factor-α levels predict symptom reduction during electroconvulsive therapy in major depressive disorder.

Sorri A, Järventausta K, Kampman O, Lehtimäki K, Björkqvist M, Tuohimaa K, Hämäläinen M, Moilanen E, Leinonen E.

Brain Behav. 2018 Feb 22;8(4):e00933. doi: 10.1002/brb3.933. eCollection 2018 Apr.

25.

Aprotinin Impacts 8-Isoprostane after Coronary Artery Bypass Grafting.

Toikkanen V, Rinne T, Nieminen R, Moilanen E, Laurikka J, Porkkala H, Tarkka M, Mennander AA.

Scand J Surg. 2018 Dec;107(4):329-335. doi: 10.1177/1457496918766720. Epub 2018 Apr 9.

PMID:
29628009
26.

The effects of adiposity and alcohol use disorder on adipokines and biomarkers of inflammation in depressed patients.

Archer M, Niemelä O, Hämäläinen M, Moilanen E, Leinonen E, Kampman O.

Psychiatry Res. 2018 Jun;264:31-38. doi: 10.1016/j.psychres.2018.03.073. Epub 2018 Mar 28.

PMID:
29626829
27.

The production of IL-6 in acute epileptic seizure: A video-EEG study.

Alapirtti T, Lehtimäki K, Nieminen R, Mäkinen R, Raitanen J, Moilanen E, Mäkinen J, Peltola J.

J Neuroimmunol. 2018 Mar 15;316:50-55. doi: 10.1016/j.jneuroim.2017.12.008. Epub 2017 Dec 15.

PMID:
29273305
28.

Time-courses of plasma IL-6 and HMGB-1 reflect initial severity of clinical presentation but do not predict poor neurologic outcome following subarachnoid hemorrhage.

Kiiski H, Långsjö J, Tenhunen J, Ala-Peijari M, Huhtala H, Hämäläinen M, Moilanen E, Öhman J, Peltola J.

eNeurologicalSci. 2016 Dec 2;6:55-62. doi: 10.1016/j.ensci.2016.11.010. eCollection 2017 Mar.

29.
30.

Signalling Profiles of Blood Leucocytes in Sepsis and in Acute Pancreatitis in Relation to Disease Severity.

Kuuliala K, Penttilä AK, Kaukonen KM, Mustonen H, Kuuliala A, Oiva J, Hämäläinen M, Moilanen E, Pettilä V, Puolakkainen P, Kylänpää L, Repo H.

Scand J Immunol. 2018 Feb;87(2):88-98. doi: 10.1111/sji.12630. Epub 2017 Dec 12.

31.

Adjuvant Breast Cancer Treatments Induce Changes in Homoarginine Level - A Prospective Observational Study.

Aula H, Skyttä T, Tuohinen S, Luukkaala T, Hämäläinen M, Virtanen V, Raatikainen P, Moilanen E, Kellokumpu-Lehtinen PL.

Anticancer Res. 2017 Dec;37(12):6815-6824.

PMID:
29187460
32.

Surgical Acute Volume-Overload Impacts Early on Myocardium - An Experimental Study.

Huuskonen C, Hämäläinen M, Bolkart R, Soininen T, Kähönen V, Paavonen T, Moilanen E, A Mennander A.

Acta Cardiol Sin. 2017 Nov;33(6):630-636. doi: 10.6515/ACS20170504A.

33.

Inflammation status of healthy young men: initial and specific responses to resistance training.

Ihalainen JK, Peltonen H, Paulsen G, Ahtiainen JP, Taipale RS, Hämäläinen M, Moilanen E, Mero AA.

Appl Physiol Nutr Metab. 2018 Mar;43(3):252-258. doi: 10.1139/apnm-2017-0315. Epub 2017 Oct 20.

PMID:
29053943
34.

Elevated serum adipsin may predict unsuccessful treatment for cows' milk allergy but other biomarkers do not.

Salmivesi S, Paassilta M, Huhtala H, Nieminen R, Moilanen E, Korppi M.

Acta Paediatr. 2018 Feb;107(2):328-332. doi: 10.1111/apa.14117. Epub 2017 Nov 9.

PMID:
29028118
35.

Microsomal Prostaglandin E Synthase-1 Expression in Inflammatory Conditions Is Downregulated by Dexamethasone: Seminal Role of the Regulatory Phosphatase MKP-1.

Tuure L, Hämäläinen M, Whittle BJ, Moilanen E.

Front Pharmacol. 2017 Sep 21;8:646. doi: 10.3389/fphar.2017.00646. eCollection 2017.

36.

Resistance training status modifies inflammatory response to explosive and hypertrophic resistance exercise bouts.

Ihalainen JK, Ahtiainen JP, Walker S, Paulsen G, Selänne H, Hämäläinen M, Moilanen E, Peltonen H, Mero AA.

J Physiol Biochem. 2017 Nov;73(4):595-604. doi: 10.1007/s13105-017-0590-0. Epub 2017 Sep 15.

PMID:
28914426
37.

TRPA1 expression is downregulated by dexamethasone and aurothiomalate in human chondrocytes: TRPA1 as a novel factor and drug target in arthritis.

Nummenmaa E, Hämäläinen M, Moilanen LJ, Moilanen T, Vuolteenaho K, Moilanen E.

RMD Open. 2017 Sep 4;3(2):e000556. doi: 10.1136/rmdopen-2017-000556. eCollection 2017. No abstract available.

38.

Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial.

Väänänen T, Vuolteenaho K, Kautiainen H, Nieminen R, Möttönen T, Hannonen P, Korpela M, Kauppi MJ, Laiho K, Kaipiainen-Seppänen O, Luosujärvi R, Uusitalo T, Uutela T, Leirisalo-Repo M, Moilanen E; NEO-RACo Study Group.

PLoS One. 2017 Aug 25;12(8):e0183294. doi: 10.1371/journal.pone.0183294. eCollection 2017.

39.

The effect of cryotherapy on total antioxidative capacity in patients with active seropositive rheumatoid arthritis.

Hirvonen H, Kautiainen H, Moilanen E, Mikkelsson M, Leirisalo-Repo M.

Rheumatol Int. 2017 Sep;37(9):1481-1487. doi: 10.1007/s00296-017-3771-9. Epub 2017 Jul 11.

PMID:
28698947
40.

Comparison of feasibility and estimates of central and peripheral nitric oxide parameters by different mathematical models.

Karvonen T, Kankaanranta H, Saarelainen S, Moilanen E, Lehtimäki L.

J Breath Res. 2017 Sep 13;11(4):047102. doi: 10.1088/1752-7163/aa7cc0.

PMID:
28665296
41.

High YKL-40 is associated with poor survival in patients with renal cell carcinoma: a novel independent prognostic marker.

Väänänen T, Kallio J, Vuolteenaho K, Ojala A, Luukkaala T, Hämäläinen M, Tammela T, Kellokumpu-Lehtinen PL, Moilanen E.

Scand J Urol. 2017 Oct;51(5):367-372. doi: 10.1080/21681805.2017.1327885. Epub 2017 Jun 23.

PMID:
28644702
42.

Adipokines played a limited role in predicting temporary growth differences between very low birthweight infants with and without bronchopulmonary dysplasia.

Lehtinen A, Korhonen P, Hyödynmaa E, Koivisto AM, Peltola T, Hämäläinen M, Moilanen E, Tammela O.

Acta Paediatr. 2017 Oct;106(10):1583-1588. doi: 10.1111/apa.13942. Epub 2017 Jul 7.

PMID:
28639282
43.

Effects of growth and aging on the reference values of pulmonary nitric oxide dynamics in healthy subjects.

Högman M, Thornadtsson A, Liv P, Hua-Huy T, Dinh-Xuan AT, Tufvesson E, Dressel H, Janson C, Koskela K, Oksa P, Sauni R, Uitti J, Moilanen E, Lehtimäki L.

J Breath Res. 2017 Sep 13;11(4):047103. doi: 10.1088/1752-7163/aa7957.

44.

Glycoprotein YKL-40 Levels in Plasma Are Associated with Fibrotic Changes on HRCT in Asbestos-Exposed Subjects.

Väänänen T, Lehtimäki L, Vuolteenaho K, Hämäläinen M, Oksa P, Vierikko T, Järvenpää R, Uitti J, Kankaanranta H, Moilanen E.

Mediators Inflamm. 2017;2017:1797512. doi: 10.1155/2017/1797512. Epub 2017 May 14.

45.

Resistin and interleukin 6 as predictive factors for recurrence and long-term prognosis in renal cell cancer.

Kallio J, Hämäläinen M, Luukkaala T, Moilanen E, Tammela TL, Kellokumpu-Lehtinen PL.

Urol Oncol. 2017 Sep;35(9):544.e25-544.e31. doi: 10.1016/j.urolonc.2017.05.005. Epub 2017 May 29.

PMID:
28572026
46.

Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Is Not Associated with Neurological Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage.

Kiiski H, Jalkanen V, Ala-Peijari M, Hämäläinen M, Moilanen E, Peltola J, Tenhunen J.

Front Neurol. 2017 Apr 18;8:144. doi: 10.3389/fneur.2017.00144. eCollection 2017.

47.

Combined aerobic and resistance training decreases inflammation markers in healthy men.

Ihalainen JK, Schumann M, Eklund D, Hämäläinen M, Moilanen E, Paulsen G, Häkkinen K, Mero AA.

Scand J Med Sci Sports. 2018 Jan;28(1):40-47. doi: 10.1111/sms.12906. Epub 2017 Jun 13.

PMID:
28453868
48.

Suppression of cytokine production by glucocorticoids is mediated by MKP-1 in human lung epithelial cells.

Keränen T, Moilanen E, Korhonen R.

Inflamm Res. 2017 May;66(5):441-449. doi: 10.1007/s00011-017-1028-4. Epub 2017 Mar 15.

PMID:
28299397
49.

Cobalt(II) Chloride Modifies the Phenotype of Macrophage Activation.

Kumanto M, Paukkeri EL, Nieminen R, Moilanen E.

Basic Clin Pharmacol Toxicol. 2017 Aug;121(2):98-105. doi: 10.1111/bcpt.12773. Epub 2017 May 25.

50.

β2-receptor agonists salbutamol and terbutaline attenuated cytokine production by suppressing ERK pathway through cAMP in macrophages.

Keränen T, Hömmö T, Moilanen E, Korhonen R.

Cytokine. 2017 Jun;94:1-7. doi: 10.1016/j.cyto.2016.07.016. Epub 2017 Feb 3.

PMID:
28162907

Supplemental Content

Loading ...
Support Center